The role of oxidative stress in diabetic cardiomyopathy: An experimental study

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 11, 2011, Pages 1241-1246

  Aksakal, E ^a   Akaras, N ^a   Kurt, M ^b   Tanboga, I H ^b   Halici, Z ^a   Odabasoglu, F ^c   Bakirci, E M ^a   Unal, B ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Erzurum Education and Research Hospital ^*  (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Cardiomyopathy; Experimental diabetes mellitus; Heart; Oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; LIPID; MYELOPEROXIDASE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME ACTIVITY; EXPERIMENTAL STUDY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RAT; REVIEW; ANIMAL; ARTICLE; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; FEMALE; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84856010292     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. WILSON PW. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am 2001; 30: 857-881. (Pubitemid 33055267)
2. BOUDINA S, ABEL ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-3223. (Pubitemid 47012236)
3. POORNIMA IG, PARIKH P, SHANNON RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006; 98: 596-605.
4. CESARIO DA, BRAR R, SHIVKUMAR K. Alterations in ion channel physiology in diabetic cardiomyopathy. Endocrinol Metab Clin North Am 2006; 35: 601-610, ix-x. (Pubitemid 44321949)
5. CHRISTLIEB AR, LONG R, UNDERWOOD RH. Renin-angiotensin-aldosterone system, electrolyte homeostasis and blood pressure in alloxan diabetes. Am J Med Sci 1979; 277: 295-303. (Pubitemid 9212257)
6. LOPASCHUK GD. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 2002; 7: 149-159. (Pubitemid 34624803)
7. KUO TH, MOORE KH, GIACOMELLI F, WIENER J. Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 1983; 32: 781-787. (Pubitemid 13038892)
8. CAI L, WANG Y, ZHOU G, CHEN T, SONG Y, LI X, KANG YJ. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 48: 1688-1697. (Pubitemid 44528172)
9. SUN Y, OBERLEY LW, LI Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
10. BRADLEY PP, PRIEBAT DA, CHRISTENSEN RD, ROTHSTEIN G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-209. (Pubitemid 12171880)
11. OHKAWA H, OHISHI N, YAGI K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358. (Pubitemid 9194347)
12. SEDLAK J, LINDSAY RH. Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
13. CAI L, LI W, WANG G, GUO L, JIANG Y, KANG YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002; 51: 1938-1948. (Pubitemid 34564309)
14. SPECTOR KS. Diabetic cardiomyopathy. Clin Cardiol 1998; 21: 885-887. (Pubitemid 28559694)
15. ALDINI G. Biomarkers for antioxidant defense and oxidative damage: principles and practical applications. Ames, Iowa: Wiley-Blackwell; 2010.
16. NISHIO Y, KANAZAWA A, NAGAI Y, INAGAKI H, KASHIWAGI A. Regulation and role of the mitochondrial transcription factor in the diabetic rat heart. Ann N Y Acad Sci 2004; 1011: 78-85. (Pubitemid 38608394)
17. ROLO AP, PALMEIRA CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212: 167-178.
18. PICONI L, QUAGLIARO L, CERIELLO A. Oxidative stress in diabetes. Clin Chem Lab Med 2003; 41: 1144-1149. (Pubitemid 37265692)
19. BAROUCH LA, BERKOWITZ DE, HARRISON RW, O'DONNELL CP, HARE JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003; 108: 754-759. (Pubitemid 36999263)
20. CAI L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med 2006; 41: 851-861. (Pubitemid 44247551)
21. UDAYAKUMAR R, KASTHURIRENGAN S, VASUDEVAN A, MARIASHIBU TS, RAYAN JJ, CHOI CW, GANAPATHI A, KIM SC. Antioxidant effect of dietary supplement Withania somnifera L. reduce blood glucose levels in alloxan-induced diabetic rats. Plant Foods Hum Nutr 2010; 65: 91-98.
22. KAUL N, SIVESKI-ILISKOVIC N, THOMAS TP, HILL M, KHAPER N, SINGAL PK. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 1995; 11: 551-554. (Pubitemid 26006223)
23. KAKKAR R, KALRA J, MANTHA SV, PRASAD K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 1995; 151: 113-119.
24. WOHAIEB SA, GODIN DV. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987; 36: 1014-1018. (Pubitemid 18088387)
25. SUN D, SHEN M, LI J, LI W, ZHANG Y, ZHAO L, ZHANG Z, YUAN Y, WANG H, CAO F. Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3beta dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 2011; 10: 4.